Poolbeg Pharma PLC
POLB.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | -£0 | -£0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.004 | -0.007 | -4.52 | -4.28 |
| % Growth | 39.4% | 99.8% | -5.6% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | £0 | £0 | £0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |